Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

Danish Headache Center

Status: Completed

Conditions: Migraine; Aura; Headache

Treatments: Drug: Saline; Drug: Levcromakalim

Study type: Interventional

Funder types: Other

Identifiers

NCT04012047

Journal-nr.: H-19023571

Details and patient eligibility

About

To investigate the role of KATP channels in migraine with aura patients.

Enrollment: 17 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Migraine with aura patients of both sexes.
• 18-60 years.
• 50-100 kg.

Exclusion criteria

• Headache less than 48 hours before the tests start
• Daily consumption of drugs of any kind other than oral contraceptives
• Pregnant or nursing women.
• Cardiovascular disease of any kind, including cerebrovascular diseases.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Quadruple Blind

---

17 participants in 2 patient groups, including a placebo group

Levcromakalim

Active Comparator group

Treatment:

Drug: Levcromakalim

Saline

Placebo Comparator group

Treatment:

Drug: Saline